ALBT closed strong with price and volumeThe chart is looking good. Volume is coming in and the price moved up creating an Alpha Candle. We shall see what it brings.
−3.03 USD
−16.71 M USD
1.26 M USD
423.80 K
About Avalon GloboCare Corp.
Sector
Industry
CEO
David K. Jin
Website
Headquarters
Freehold
Founded
2014
FIGI
BBG008648HM7
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALBT is 4.10 USD — it has increased by 14.85% in the past 24 hours. Watch Avalon GloboCare Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Avalon GloboCare Corp. stocks are traded under the ticker ALBT.
ALBT stock has risen by 9.33% compared to the previous week, the month change is a 54.72% rise, over the last year Avalon GloboCare Corp. has showed a −45.03% decrease.
ALBT reached its all-time high on Jan 22, 2019 with the price of 2,025.00 USD, and its all-time low was 2.11 USD and was reached on Nov 4, 2024. View more price dynamics on ALBT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALBT stock is 17.14% volatile and has beta coefficient of 0.62. Track Avalon GloboCare Corp. stock price on the chart and check out the list of the most volatile stocks — is Avalon GloboCare Corp. there?
Today Avalon GloboCare Corp. has the market capitalization of 3.91 M, it has decreased by −33.83% over the last week.
Yes, you can track Avalon GloboCare Corp. financials in yearly and quarterly reports right on TradingView.
ALBT net income for the last quarter is −1.68 M USD, while the quarter before that showed −2.13 M USD of net income which accounts for 21.24% change. Track more Avalon GloboCare Corp. financial stats to get the full picture.
No, ALBT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 5.00 employees. See our rating of the largest employees — is Avalon GloboCare Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Avalon GloboCare Corp. EBITDA is −3.50 M USD, and current EBITDA margin is −545.69%. See more stats in Avalon GloboCare Corp. financial statements.
Like other stocks, ALBT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Avalon GloboCare Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Avalon GloboCare Corp. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Avalon GloboCare Corp. stock shows the sell signal. See more of Avalon GloboCare Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.